|
EPC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.234790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.643900E-04 |
| Normal-vs-Stage2 |
6.202200E-01 |
| Normal-vs-Stage3 |
4.497200E-01 |
| Normal-vs-Stage4 |
9.140300E-02 |
| Stage1-vs-Stage2 |
1.015370E-01 |
| Stage1-vs-Stage3 |
2.597600E-04 |
| Stage1-vs-Stage4 |
3.86119999999934E-05 |
| Stage2-vs-Stage3 |
3.192800E-01 |
| Stage2-vs-Stage4 |
9.861600E-02 |
| Stage3-vs-Stage4 |
3.432000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.236030E-01 |
| Normal-vs-AfricanAmerican |
9.007000E-01 |
| Normal-vs-Asian |
1.825430E-01 |
| Caucasian-vs-AfricanAmerican |
4.863600E-01 |
| Caucasian-vs-Asian |
1.083770E-01 |
| AfricanAmerican-vs-Asian |
1.376170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.920800E-01 |
| Normal-vs-Female |
9.343600E-03 |
| Male-vs-Female |
2.179900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.720200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.659600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.411600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.045200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.230000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.494200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.616400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.986400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.049800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.058000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.784700E-03 |
| Normal-vs-Grade 2 |
8.17499999999916E-05 |
| Normal-vs-Grade 3 |
7.697600E-01 |
| Normal-vs-Grade 4 |
4.003200E-03 |
| Grade 1-vs-Grade 2 |
2.604400E-02 |
| Grade 1-vs-Grade 3 |
6.3941999999928E-05 |
| Grade 1-vs-Grade 4 |
1.73859999996751E-06 |
| Grade 2-vs-Grade 3 |
2.23249999999897E-05 |
| Grade 2-vs-Grade 4 |
3.83239999734997E-08 |
| Grade 3-vs-Grade 4 |
6.976800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.08419999977905E-07 |
| Normal-vs-ccB subtype |
2.156800E-01 |
| ccA subtype-vs-ccB subtype |
7.1187000738604E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.466410E-01 |
| Normal-vs-N1 |
1.777440E-01 |
| N0-vs-N1 |
5.816300E-02 |
|
|
